CNY 11.01
(-0.63%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 465.75 Million CNY | -92.16% |
2022 | 1.24 Billion CNY | -2.52% |
2021 | 3 Billion CNY | -30.91% |
2020 | 3.66 Billion CNY | 115.0% |
2019 | 2.31 Billion CNY | 48.15% |
2018 | 1.56 Billion CNY | -38.84% |
2017 | 2.41 Billion CNY | 22.99% |
2016 | 604.07 Million CNY | 14.17% |
2015 | 84.93 Million CNY | 6.25% |
2014 | 1.33 Billion CNY | 13.35% |
2013 | 1.39 Billion CNY | 18.28% |
2012 | 1.19 Billion CNY | -60.19% |
2011 | 3.17 Billion CNY | 95.32% |
2010 | 1.6 Billion CNY | 3.1% |
2009 | 1.55 Billion CNY | 34.54% |
2008 | 1.16 Billion CNY | -52.06% |
2007 | 2.42 Billion CNY | 276.47% |
2006 | 715 Million CNY | 267.9% |
2005 | 190.25 Million CNY | 38.32% |
2004 | 134.61 Million CNY | 28.87% |
2003 | 100.12 Million CNY | -9.16% |
2002 | 110.86 Million CNY | -31.46% |
2001 | 159.9 Million CNY | -29.98% |
2000 | 226.86 Million CNY | 151.64% |
1999 | 90.87 Million CNY | -6.23% |
1998 | 92.31 Million CNY | 0.21% |
1997 | 97.13 Million CNY | 39.48% |
1996 | 69.63 Million CNY | -3.04% |
1995 | 71.82 Million CNY | -93.52% |
1994 | 1.1 Billion CNY | 70.27% |
1993 | 651.3 Million CNY | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q3 | 783.07 Million CNY | 236.25% |
2024 Q1 | 298.06 Million CNY | 125.36% |
2024 Q2 | 162.71 Million CNY | 110.02% |
2023 Q1 | 551.16 Million CNY | -9.8% |
2023 FY | - CNY | -92.16% |
2023 Q4 | -437.17 Million CNY | -220.58% |
2023 Q3 | 362.55 Million CNY | -44.49% |
2023 Q2 | 653.13 Million CNY | 18.5% |
2022 Q4 | 611.02 Million CNY | 18.38% |
2022 Q1 | 850 Million CNY | 115.79% |
2022 Q3 | 516.14 Million CNY | -48.21% |
2022 FY | - CNY | -2.52% |
2022 Q2 | 996.65 Million CNY | 17.25% |
2021 Q3 | 900.66 Million CNY | -14.79% |
2021 FY | - CNY | -30.91% |
2021 Q1 | 717.92 Million CNY | -22.23% |
2021 Q2 | 1.05 Billion CNY | 47.23% |
2021 Q4 | 393.91 Million CNY | -56.26% |
2020 Q4 | 923.12 Million CNY | -54.96% |
2020 Q3 | 2.04 Billion CNY | 79.53% |
2020 FY | - CNY | 115.0% |
2020 Q1 | 550.06 Million CNY | 17.3% |
2020 Q2 | 1.14 Billion CNY | 107.53% |
2019 FY | - CNY | 48.15% |
2019 Q1 | 788.93 Million CNY | 215.17% |
2019 Q2 | 410.27 Million CNY | -48.0% |
2019 Q4 | 468.94 Million CNY | -21.19% |
2019 Q3 | 595 Million CNY | 45.03% |
2018 Q4 | 250.32 Million CNY | -50.19% |
2018 FY | - CNY | -38.84% |
2018 Q3 | 502.54 Million CNY | -30.21% |
2018 Q1 | 53.44 Million CNY | -96.56% |
2018 Q2 | 720.11 Million CNY | 1247.35% |
2017 Q1 | 153.5 Million CNY | -84.27% |
2017 FY | - CNY | 22.99% |
2017 Q3 | 195.56 Million CNY | -83.8% |
2017 Q4 | 1.55 Billion CNY | 693.38% |
2017 Q2 | 1.2 Billion CNY | 686.41% |
2016 Q3 | 387.42 Million CNY | -63.6% |
2016 Q4 | 975.55 Million CNY | 151.81% |
2016 FY | - CNY | 14.17% |
2016 Q2 | 1.06 Billion CNY | 616.23% |
2016 Q1 | 148.6 Million CNY | -80.8% |
2015 FY | - CNY | 6.25% |
2015 Q4 | 773.87 Million CNY | 253.34% |
2015 Q3 | 219.01 Million CNY | -84.82% |
2015 Q2 | 1.44 Billion CNY | 693.49% |
2015 Q1 | 181.83 Million CNY | -83.12% |
2014 Q3 | 181.57 Million CNY | -59.35% |
2014 Q4 | 1.07 Billion CNY | 493.17% |
2014 Q1 | 120.77 Million CNY | -86.09% |
2014 FY | - CNY | 13.35% |
2014 Q2 | 446.72 Million CNY | 269.89% |
2013 Q3 | 104.25 Million CNY | -80.29% |
2013 Q2 | 528.9 Million CNY | 331.8% |
2013 Q1 | 122.48 Million CNY | -72.48% |
2013 FY | - CNY | 18.28% |
2013 Q4 | 868.31 Million CNY | 732.86% |
2012 Q1 | 237.19 Million CNY | -90.66% |
2012 FY | - CNY | -60.19% |
2012 Q2 | 552.35 Million CNY | 132.87% |
2012 Q4 | 445.04 Million CNY | 115.69% |
2012 Q3 | 206.34 Million CNY | -62.64% |
2011 Q1 | 154.05 Million CNY | -86.18% |
2011 Q3 | 255.98 Million CNY | -52.6% |
2011 FY | - CNY | 95.32% |
2011 Q4 | 2.53 Billion CNY | 891.8% |
2011 Q2 | 540.08 Million CNY | 250.58% |
2010 FY | - CNY | 3.1% |
2010 Q2 | 109.54 Million CNY | -24.4% |
2010 Q4 | 1.11 Billion CNY | 460.89% |
2010 Q1 | 144.91 Million CNY | -89.44% |
2010 Q3 | 198.77 Million CNY | 81.45% |
2009 Q3 | 54.44 Million CNY | -23.16% |
2009 FY | - CNY | 34.54% |
2009 Q4 | 1.37 Billion CNY | 2421.65% |
2009 Q2 | 70.85 Million CNY | 144.43% |
2009 Q1 | 28.98 Million CNY | -96.84% |
2008 Q1 | 61.11 Million CNY | -97.2% |
2008 FY | - CNY | -52.06% |
2008 Q4 | 916.42 Million CNY | 1448.19% |
2008 Q3 | 59.19 Million CNY | -38.07% |
2008 Q2 | 95.58 Million CNY | 56.41% |
2007 Q2 | 1.13 Billion CNY | 3122.44% |
2007 Q1 | 35.28 Million CNY | -92.6% |
2007 Q4 | 2.18 Billion CNY | 1969.51% |
2007 FY | - CNY | 276.47% |
2007 Q3 | 105.38 Million CNY | -90.73% |
2006 Q4 | 476.93 Million CNY | 347.48% |
2006 Q2 | 154.05 Million CNY | 613.91% |
2006 Q1 | 21.57 Million CNY | -83.12% |
2006 FY | - CNY | 267.9% |
2006 Q3 | 106.58 Million CNY | -30.82% |
2005 Q2 | 48.35 Million CNY | 207.05% |
2005 FY | - CNY | 38.32% |
2005 Q1 | 15.74 Million CNY | -67.59% |
2005 Q3 | 20.92 Million CNY | -56.74% |
2005 Q4 | 127.8 Million CNY | 510.9% |
2004 Q4 | 48.6 Million CNY | 55.89% |
2004 Q2 | 53.84 Million CNY | 184.54% |
2004 Q1 | 18.92 Million CNY | -26.84% |
2004 FY | - CNY | 28.87% |
2004 Q3 | 31.17 Million CNY | -42.1% |
2003 Q4 | 25.86 Million CNY | -22.08% |
2003 Q1 | 11.6 Million CNY | -72.08% |
2003 FY | - CNY | -9.16% |
2003 Q2 | 54.17 Million CNY | 366.81% |
2003 Q3 | 33.19 Million CNY | -38.72% |
2002 FY | - CNY | -31.46% |
2002 Q4 | 41.55 Million CNY | 334.13% |
2002 Q3 | -17.75 Million CNY | -130.03% |
2002 Q2 | 59.11 Million CNY | 422.19% |
2002 Q1 | 11.32 Million CNY | 0.0% |
2001 FY | - CNY | -29.98% |
2000 FY | - CNY | 151.64% |
1999 FY | - CNY | -6.23% |
1998 FY | - CNY | 0.21% |
1997 FY | - CNY | 39.48% |
1996 FY | - CNY | -3.04% |
1996 Q2 | -100.39 Million CNY | -176.21% |
1996 Q1 | 131.73 Million CNY | 0.0% |
1995 FY | - CNY | -93.52% |
1994 FY | - CNY | 70.27% |
1993 FY | - CNY | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
China Meheco Group Co., Ltd. | 2.27 Billion CNY | 79.514% |
Shanghai Pharmaceuticals Holding Co., Ltd | 11.24 Billion CNY | 95.858% |
Guangxi LiuYao Group Co., Ltd | 1.28 Billion CNY | 63.754% |